Safe consumption sites: Study identifies policy change strategies and challenges
A new qualitative study from the Johns Hopkins Bloomberg School of Public Health identifies several key lessons from early efforts to establish sanctioned safe consumption sites in five U.S. communities. The results offer insights on one approach some localities are exploring to address the escalating drug overdose crisis in the U.S.
Fraction of US outpatient treatment centers offer medication for opioid addiction
Study finds that most substance use disorder treatment facilities still do not offer medication treatment for opioid use disorder
THE GLOBAL STATE OF HARM REDUCTION 2018
This report was made possible by the collaborative input of harm reduction organisations networks, drug user organisations, researchers, academics and advocates.
Medically Supervised Injecting Facility
A Medically Supervised Injecting Facility (MSIF) is a healthcare facility where people can inject drugs, obtained elsewhere, under the supervision of trained health professionals.
Words matter: a call for humanizing and respectful language to describe people who experience incarceration
Words matter when describing people involved in the criminal justice system because language can have a significant impact upon health, wellbeing, and access to health information and services. However, terminology used in policies, programs, and research publications is often derogatory, stigmatizing, and dehumanizing.
Drug consumption rooms: an overview of provision and evidence.
Refreshing its overview of the use of drug consumption rooms, the European Union’s drug misuse monitoring centre says the evidence still contradicts concerns that such facilities encourage drug use, delay treatment entry, or aggravate problems arising from local drug markets – finding instead that both the users and the community stand to benefit.
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study.
Based on detailed treatment records kept by the Canadian province of British Columbia, a slow taper liberally interspersed with stabilisation periods offers the best chance of sustainably withdrawing from methadone without severe relapse, but still very few manage to avoid this risk – an argument for careful consideration and informed consent before making the attempt.
Share this on: